These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26097685)

  • 1. Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity.
    Koltai T
    F1000Res; 2015; 4():9. PubMed ID: 26097685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
    Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
    J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
    Guan M; Fousek K; Jiang C; Guo S; Synold T; Xi B; Shih CC; Chow WA
    Clin Cancer Res; 2011 Apr; 17(7):1796-806. PubMed ID: 21355074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review).
    Allegra A; Innao V; Allegra AG; Pulvirenti N; Pugliese M; Musolino C
    Oncol Rep; 2020 Jun; 43(6):1729-1736. PubMed ID: 32236596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy.
    Gills JJ; Lopiccolo J; Dennis PA
    Autophagy; 2008 Jan; 4(1):107-9. PubMed ID: 18000394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
    Arodola OA; Soliman ME
    Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents.
    Ben-Romano R; Rudich A; Etzion S; Potashnik R; Kagan E; Greenbaum U; Bashan N
    Antivir Ther; 2006; 11(8):1051-60. PubMed ID: 17302375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
    Guan M; Fousek K; Chow WA
    FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
    Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC
    Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nelfinavir inhibits human DDI2 and potentiates cytotoxicity of proteasome inhibitors.
    Gu Y; Wang X; Wang Y; Wang Y; Li J; Yu FX
    Cell Signal; 2020 Nov; 75():109775. PubMed ID: 32916277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition.
    Subeha MR; Goyeneche AA; Bustamante P; Lisio MA; Burnier JV; Telleria CM
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.
    Meier-Stephenson V; Riemer J; Narendran A
    Onco Targets Ther; 2017; 10():2581-2593. PubMed ID: 28553123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and intestinal contributions to pharmacokinetic interaction of indinavir with amprenavir, nelfinavir and saquinavir in rats.
    Gao W; Kishida T; Kageyama M; Kimura K; Yoshikawa Y; Shibata N; Takada K
    Antivir Chem Chemother; 2002 Jan; 13(1):17-26. PubMed ID: 12180646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir.
    Subeha MR; Telleria CM
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.
    Pore N; Gupta AK; Cerniglia GJ; Maity A
    Neoplasia; 2006 Nov; 8(11):889-95. PubMed ID: 17132220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.
    Soprano M; Sorriento D; Rusciano MR; Maione AS; Limite G; Forestieri P; D'Angelo D; D'Alessio M; Campiglia P; Formisano P; Iaccarino G; Bianco R; Illario M
    PLoS One; 2016; 11(6):e0155970. PubMed ID: 27280849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human preadipocyte proteasomal activity by HIV protease inhibitors or specific inhibitor lactacystin leads to a defect in adipogenesis, which involves matrix metalloproteinase-9.
    De Barros S; Zakaroff-Girard A; Lafontan M; Galitzky J; Bourlier V
    J Pharmacol Exp Ther; 2007 Jan; 320(1):291-9. PubMed ID: 17038510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nelfinavir induces TRAIL receptor upregulation in ovarian cancer cells.
    Brüning A; Vogel M; Burger P; Rahmeh M; Gingelmaier A; Friese K; Lenhard M; Burges A
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1309-14. PubMed ID: 19000651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation.
    Gantt S; Gachelet E; Carlsson J; Barcy S; Casper C; Lagunoff M
    Adv Virol; 2015; 2015():687162. PubMed ID: 25709648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.